EPIX Pharmaceuticals Reports First Quarter 2006 Results

May 1, 2006 |

1 min read

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 1, 2006--EPIX Pharmaceuticals, Inc. (Nasdaq: EPIX - News), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), today announced results for the first quarter 2006.

Earnings

MORE ON THIS TOPIC

Feb 19, 2020 Foster City / CA / USA - Gilead corporate headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs

Infectious disease

Gilead to Provide New HIV Drug to Lower-Income Countries Through Novel Philanthropic Partnership

July 10, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Century Halves Headcount to ‘Right Size’ Operations

July 10, 2025

·

155 min read

·

BioSpace Editorial Staff

Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.

Series B

Nuclidium Nets $99M Series B for Copper-Based Radiopharma Platform

July 10, 2025

·

2 min read

·

Tristan Manalac

A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.

Gene therapy

AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M

July 9, 2025

·

1 min read

·

Dan Samorodnitsky